1
Joseph P Hammang, E Edward Baetge, William G Tsiarias, Peter D Spear: Device and method for treating ophthalmic diseases. Neurotech, Ivor R Elrifi, Mintz Levin Cohn Ferris Glovsky and Popeo P C, October 9, 2001: US06299895 (76 worldwide citation)

A method and device for delivering a biologically active molecule to the eye, either intraocularly or periocularly, and method and device for treating ophthalmic disorders in a patient suffering therefrom.


2
Joseph P Hammang, E Edward Baetge, Peter D Spear, William G Tsiaras: Method for treating ophthalmic diseases. CytoTherapeutics, Mintz Levin Cohn Ferris Glovsky and Popeo P C, May 18, 1999: US05904144 (71 worldwide citation)

The present invention provides novel devices and methods for continuous, controlled delivery of a biologically active molecule to the eye, either intraocularly or periocularly, to treat ophthalmic disorders. A capsule is surgically placed in the desired location in the eye. The capsule includes cell ...


3
Joseph P Hammang, E Edward Baetge, William G Tsiarias, Peter D Spear: Device and method for treating ophthalmic diseases. Neurotech, Ivor R Elrifi Esq, Christina V Karnakis Esq, Mintz Levin Cohn Ferris Glovsky and Popeo P C, August 20, 2002: US06436427 (51 worldwide citation)

The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.


4
Joseph P Hammang, E Edward Baetge, William G Tsiarias, Peter D Spear: Device and method for treating ophthalmic diseases. Neurotech, Ivor R Elrifi Esq, Christine V Karnakis Esq, Mintz Levin Cohn Ferris Glovsky and Popep P C, November 18, 2003: US06649184 (6 worldwide citation)

The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.


5
Joseph P Hammang, E Edward Baetge, William G Tsiarias, Peter D Spear: Device and method for treating ophthalmic diseases. Ivor R Elrifi, Mintz Levin, May 23, 2002: US20020061327-A1

The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.


6
Joseph P Hammang, E Edward Baetge, William G Tsiarias, Peter D Spear: Device and method for treating ophthalmic diseases. Ivor R Elrifi Esquire, c o MINTZ LEVIN, February 13, 2003: US20030031700-A1

The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.


7
Youri Barba, Alister F Fyffe, Max B Barbank, Kevin H Betz, James B Mackay, Diego M Nonis, Peter D Spear, Mark A Tillotson, Yuval Urieru, Tamura Itsuro, Fujita Satoshi, Takae Tsutomu, Iida Atsushi: Detector for weak magnetic field. Ctf Syst, Kansai Shin Gijutsu Kenkyusho, Osaka Gas, April 23, 1996: JP1996-103420

PURPOSE: To enable a detector for detecting the weak magnetic field generated by the brain in the head of a human being and the position of the current source generating the brain magnetic field to conduct the detection with high precision by supporting a particular magnetic field detecting assembly ...